Aneustat

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background:Docetaxel used for first-line treatment of advanced prostate cancer (PCa) is only marginally effective. We previously… (More)
Is this relevant?
2018
2018
Aneustat (OMN54) is a multivalent, botanical anticancer candidate therapeutic. A recent Phase-I clinical trial has indicated that… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
......................................................................................................................................... ii Lay Summary ............................................................................................................................... iv Preface .............................................................................................................................................v Table of 
  • figure 1.1
  • figure 2.1
  • figure 2.2
  • figure 2.3
  • figure 2.4
Is this relevant?
2014
2014
The current first-line treatment for advanced metastatic prostate cancer, i.e. docetaxel-based therapy, is only marginally… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2007
2007
C67 Aneustat (OMN54), a natural product derivative, has anti-tumor, anti-inflammatory and immuno-modulatory activity as a single… (More)
Is this relevant?